Mirati Therapeutics announced that it has been added to the Russell 2000 Index, effective as of the open of the market on Monday, June 25, 2018, following Russell’s annual reconstitution of its comprehensive set of U.S. and global equity indexes. The Russell 2000 Index measures the performance of the small-cap segment of the U.S. equity market. The index is a subset of the Russell 3000 Index and represents approximately 10% of the total market capitalization of that index.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.